Loading...
Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) is a rare complication following solid organ transplantation and allogeneic hematopoietic stem cell transplantation (Allo-HSCT), which gives rise to high mortality rates. MATERIAL/METHODS: This was a single-center retrospective analysis...
Na minha lista:
| Udgivet i: | Ann Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Scientific Literature, Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463616/ https://ncbi.nlm.nih.gov/pubmed/30940797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.914101 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|